# Vivid Vision

> Vivid Vision is a San Francisco medical technology company that turns virtual reality headsets into tools for vision care. Founded in 2014 by programmer James Blaha, who built the first prototype to treat his own lazy eye, the company started with VR games for amblyopia and strabismus and now runs two lines: a clinical and at-home vision therapy suite used in clinics across 50+ countries, and Vivid Vision Perimetry (VVP), a VR-based visual field test being adopted as a digital endpoint in pharmaceutical clinical trials for glaucoma, AMD, and geographic atrophy.

- **Founded:** 2014
- **Headquarters:** San Francisco, California, United States
- **Founders:** James Blaha (Founder & CEO), Manish Gupta (Co-Founder)
- **Team size:** ~62 employees
- **Products:** Vivid Vision Clinical (for clinics), Vivid Vision Home, Vivid Vision Perimetry (VVP)
- **Notable:** Founder improved his own weak eye toward near-20/20 using the first prototype, Launched one of the first commercial VR vision therapy suites for clinics in 2015, Reached use by 100,000+ patients across 50+ countries

## Products & services

- **Vivid Vision Clinical (for clinics)** — A VR vision therapy suite for optometrists and ophthalmologists treating amblyopia, strabismus, and convergence insufficiency through interactive games that present separate images to each eye.
- **Vivid Vision Home** — A doctor-prescribed at-home version of the vision therapy system so patients can continue training between clinic visits.
- **Vivid Vision Perimetry (VVP)** — A VR-based visual field / microperimetry test used as a digital endpoint in clinical trials for glaucoma, AMD, and geographic atrophy, enabling precise at-home visual field monitoring.

## Achievements

- Founder improved his own weak eye toward near-20/20 using the first prototype
- Launched one of the first commercial VR vision therapy suites for clinics in 2015
- Reached use by 100,000+ patients across 50+ countries
- VVP study reported better at-home fixation precision (0.55 deg) than in-clinic MAIA microperimetry (1.2 deg)
- Reported near-100% patient adherence to assigned at-home VR testing sessions
- Named a finalist in the VSP Global Innovation Challenge 2025

## Latest updates

- **2025-09** — Named a finalist in the VSP Global Innovation Challenge 2025.
- **2025-03** — Published work on VR perimetry for improving endpoint precision in geographic atrophy clinical trials.
- **2025-02** — Study led by Dr. Karl Csaky (supported by Regeneron) presented at the Macula Society showed at-home VVP matched and exceeded in-clinic microperimetry precision.

## Links

- Website: https://seevividly.com
- LinkedIn: http://www.linkedin.com/company/vivid-vision
- Twitter/X: http://www.twitter.com/SeeVividly
- YouTube: https://www.youtube.com/c/VividVision
- Instagram: https://www.instagram.com/seevividly/
- Facebook: http://www.facebook.com/SeeVividly

---

Profile page: https://yespress.io/vivid-vision
Published by YesPress — https://yespress.io
Last updated: 2026-07-10